SEC Form 4 · accession 0001144204-17-047742
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard G Johnson
Officer — Chief Financial Officer
Period of report
Sep 8, 2017
Accepted (ET)
Sep 12, 2017 · 9:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 8, 2017 | M | 14,623 | $11.83 | A | 14,623 | D | |
| Class A Common StockF2 | Sep 8, 2017 | S | 14,623 | $36.19 | D | 0 | D | |
| Class A Common Stock | Sep 11, 2017 | M | 9,600 | $11.83 | A | 9,600 | D | |
| Class A Common StockF3 | Sep 11, 2017 | S | 9,600 | $36.26 | D | 0 | D | |
| Class A Common Stock | Sep 12, 2017 | M | 12,270 | $11.83 | A | 12,270 | D | |
| Class A Common StockF4 | Sep 12, 2017 | S | 12,270 | $36.42 | D | 0 | D | |
| Class A Common Stock | Sep 12, 2017 | M | 10,771 | $11.83 | A | 10,771 | D | |
| Class A Common StockF5 | Sep 12, 2017 | S | 10,771 | $36.42 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock | $11.83 | Sep 8, 2017 | M | 14,623 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 14,623 | 21,870 | D |
| Option to purchase Common Stock | $11.83 | Sep 11, 2017 | M | 9,600 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 9,600 | 12,270 | D |
| Option to purchase Common Stock | $11.83 | Sep 12, 2017 | M | 12,270 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 12,270 | 0 | D |
| Option to purchase Common Stock | $11.83 | Sep 12, 2017 | M | 10,771 | D | Mar 1, 2013 | Feb 28, 2019 | Class A Common Stock | 10,771 | 22,379 | D |
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.70, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.45, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.65, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.65, inclusive.